Parallel Advisors’s CollPlant Biotechnologies OPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7
Closed -$25 – 4059
2026
Q2
$25 Hold
7
– – ﹤0.01% 3906
2026
Q1
$38 Sell
7
-318
-98% -$3.21K ﹤0.01% 3800
2025
Q4
$4.56K Hold
325
– – ﹤0.01% 2879
2025
Q3
$8.75K Hold
325
– – ﹤0.01% 2576
2025
Q2
$4.42K Hold
325
– – ﹤0.01% 2786
2025
Q1
$8.39K Hold
325
– – ﹤0.01% 2502
2024
Q4
$11.7K Hold
325
– – ﹤0.01% 2361
2024
Q3
$16.2K Hold
325
– – ﹤0.01% 2201
2024
Q2
$16.2K Sell
325
-83
-20% -$4.6K ﹤0.01% 2098
2024
Q1
$21.8K Buy
408
+401
+5,729% +$21.7K ﹤0.01% 1931
2023
Q4
$454 Sell
7
-849
-99% -$46.4K ﹤0.01% 3071
2023
Q3
$47.7K Sell
856
-105
-11% -$6.95K ﹤0.01% 1418
2023
Q2
$78.4K Hold
961
– – ﹤0.01% 1187
2023
Q1
$67.5K Sell
961
-303
-24% -$29.7K ﹤0.01% 1226
2022
Q4
$106K Sell
1,264
-374
-23% -$25.6K ﹤0.01% 970
2022
Q3
$111K Hold
1,638
– – 0.01% 921
2022
Q2
$131K Hold
1,638
– – 0.01% 857
2022
Q1
$192K Sell
1,638
-369
-18% -$40.6K 0.01% 750
2021
Q4
$328K Sell
2,007
-122
-6% -$21.8K 0.01% 577
2021
Q3
$360K Buy
2,129
+1,699
+395% +$305K 0.01% 505
2021
Q2
$91K Sell
430
-82
-16% -$13.1K ﹤0.01% 981
2021
Q1
$69K Buy
512
+193
+61% +$29.1K ﹤0.01% 1035
2020
Q4
$34K Buy
+319
New +$25.8K ﹤0.01% 1254

Other funds holding OPHI

Parallel Advisors's OPHI Position: Q3 2026 in Review

Parallel Advisors sold out of CollPlant Biotechnologies (OPHI) in Q3 2026, closing a stake of 7 shares — an estimated $25 sold.

Parallel Advisors first reported a position in OPHI in Q4 2020 and held it in 23 quarters. The position peaked at $360K in Q3 2021. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

  • Parallel Advisors reported no remaining CollPlant Biotechnologies position as of Q3 2026 after selling out during the quarter.
  • Parallel Advisors sold 7 CollPlant Biotechnologies shares in Q3 2026, an estimated $25.
  • Parallel Advisors first reported a position in CollPlant Biotechnologies in Q4 2020 and held it in 23 quarters.
  • Parallel Advisors's CollPlant Biotechnologies position peaked at $360K in Q3 2021.
  • 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.